Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.58M | 1.65M | 1.59M | 1.85M | 2.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.85M | 1.89M | 1.59M | 1.85M | 2.87M |
| Operating Income | -1.85M | -1.89M | -1.59M | -1.85M | -2.87M |
| Income Before Tax | -2.90M | -4.09M | -2.23M | -2.07M | -2.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.90M | -4.09M | -2.23M | -2.07M | -2.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.90M | -4.09M | -2.23M | -2.07M | -2.96M |
| EBIT | -1.85M | -1.89M | -1.59M | -1.85M | -2.87M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.05 | -0.12 | -0.08 | -0.08 | -0.18 |
| Normalized Basic EPS | -0.03 | -0.07 | -0.05 | -0.05 | -0.11 |
| EPS Diluted | -0.05 | -0.12 | -0.08 | -0.08 | -0.18 |
| Normalized Diluted EPS | -0.03 | -0.07 | -0.05 | -0.05 | -0.11 |
| Average Basic Shares Outstanding | 59.42M | 33.95M | 27.52M | 27.22M | 16.69M |
| Average Diluted Shares Outstanding | 59.42M | 33.95M | 27.52M | 27.22M | 16.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |